Precision BioSciences Net Profit Margin Over Time
| DTIL Stock | USD 6.18 0.03 0.48% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Precision BioSciences Performance and Precision BioSciences Correlation. Precision |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Precision BioSciences. If investors know Precision will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Precision BioSciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.4 | Revenue Per Share 12.872 | Quarterly Revenue Growth (0.96) | Return On Assets (0.06) | Return On Equity 0.2444 |
The market value of Precision BioSciences is measured differently than its book value, which is the value of Precision that is recorded on the company's balance sheet. Investors also form their own opinion of Precision BioSciences' value that differs from its market value or its book value, called intrinsic value, which is Precision BioSciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Precision BioSciences' market value can be influenced by many factors that don't directly affect Precision BioSciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Precision BioSciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Precision BioSciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Precision BioSciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Net Profit Margin Analysis
Compare Precision BioSciences and related stocks such as X4 Pharmaceuticals, Acumen Pharmaceuticals, and Inozyme Pharma Net Profit Margin Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| XFOR | (12.2917) | (12.2917) | (12.2917) | (12.2917) | (12.2917) | (12.2917) | (12.2917) | (12.2917) | (12.2917) | (20.7103) | (20.7103) | (20.7103) | (20.7103) | (23.82) | (25.01) |
| ABOS | (4.6329) | (4.6329) | (4.6329) | (4.6329) | (4.6329) | (4.6329) | (4.6329) | (4.6329) | (4.6329) | (4.6329) | (5.1003) | (5.1003) | (5.1003) | (5.87) | (6.16) |
| INZY | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| TERN | (50.158) | (50.158) | (50.158) | (50.158) | (50.158) | (50.158) | (50.158) | (50.158) | (50.158) | (50.158) | (50.158) | (50.158) | (50.158) | (45.14) | (47.4) |
| DAWN | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| ELDN | (190) | (190) | (190) | (190) | (190) | (190) | (190) | (190) | (190) | (190) | (190) | (190) | (190) | (171) | (180) |
| HOOK | (2.1283) | (2.1283) | (2.1283) | (2.1283) | (2.1283) | (2.1283) | (2.1283) | (2.1283) | (2.1283) | (3.6038) | (2.2509) | (4.1015) | (4.5558) | (4.0529) | (4.26) |
| MREO | 11.8099 | 11.8099 | 11.8099 | 11.8099 | 11.8099 | 11.8099 | 11.8099 | 11.8099 | 286 | 286 | (416) | 0.349 | (22.6914) | (2.9466) | (3.09) |
| PASG | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| BDTX | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| ALEC | (36.3221) | (36.3221) | (36.3221) | (36.3221) | (36.3221) | (36.3221) | (36.3221) | (8.6961) | (1.8878) | (4.7039) | (8.6721) | (0.1353) | (0.9977) | (1.3434) | (1.41) |
| STOK | (7.5058) | (7.5058) | (7.5058) | (7.5058) | (7.5058) | (7.5058) | (7.5058) | (7.5058) | (7.5058) | (7.5058) | (7.5058) | (7.5058) | (7.5058) | (11.9247) | (12.52) |
| PLRX | 0.0032 | 0.0032 | 0.0032 | 0.0032 | 0.0032 | 0.0032 | 0.0032 | 0.0032 | 0.0032 | 0.0032 | (0.9505) | (2.3649) | (12.545) | (102) | (97.01) |
| DYN | 0.0851 | (1.0379) | (119) | (119) | (0.0457) | 0.0594 | (0.9078) | 0.1502 | 0.1502 | 0.1502 | 0.1502 | 0.1502 | 0.1502 | 0.17 | 0.18 |
| CYTK | (1.875) | (11.965) | (5.1614) | (1.1001) | (0.312) | (1.3086) | 0.1546 | (9.5594) | (3.3741) | (5.5476) | (2.94) | (3.4414) | (4.2558) | (69.8863) | (66.39) |
| RVMD | (2.0724) | (2.0724) | (2.0724) | (2.0724) | (2.0724) | (2.0724) | (2.0724) | (2.0724) | (2.0724) | (0.9525) | (2.5163) | (6.1167) | (7.0295) | (37.6828) | (35.8) |
Precision BioSciences and related stocks such as X4 Pharmaceuticals, Acumen Pharmaceuticals, and Inozyme Pharma Net Profit Margin description
The percentage of revenue left after all expenses have been deducted from sales. The measure is calculated by dividing net profit by revenue.My Equities
My Current Equities and Potential Positions
| Precision BioSciences | DTIL |
| Classification | Pharmaceutical Products |
| Location | North Carolina; U.S.A |
| Exchange | NASDAQ Exchange |
USD 6.18
Check out Precision BioSciences Performance and Precision BioSciences Correlation. For more information on how to buy Precision Stock please use our How to buy in Precision Stock guide.You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Precision BioSciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.